ORAMED PHARMACEUTICALS INC. Revenue Breakdown
No Revenue Breakdown for ORMP on this site yet.
- 2025-12-31: Others Not split by product in the filing$2.00M100.00%; Total revenue $2.00M.
- 2023-12-31: Others Not split by product in the filing$1.34M100.00%; Total revenue $1.34M.
- 2022-12-31: Others Not split by product in the filing$2.70M100.00%; Total revenue $2.70M.
- 2021-08-31: Others Not split by product in the filing$2.70M100.00%; Total revenue $2.70M.
Source checked: the stored Revenue Breakdown page for ORMP.
Revenue by product
Each year (12 month)
| Fiscal year end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product in the filing $2.00M 100.00% | $2.00M |
| 2023-12-31 | Not split by product in the filing $1.34M 100.00% | $1.34M |
| 2022-12-31 | Not split by product in the filing $2.70M 100.00% | $2.70M |
| 2021-08-31 | Not split by product in the filing $2.70M 100.00% | $2.70M |
| 2020-08-31 | Not split by product in the filing $2.71M 100.00% | $2.71M |
| 2019-08-31 | Not split by product in the filing $2.70M 100.00% | $2.70M |
| 2018-08-31 | Not split by product in the filing $2.45M 100.00% | $2.45M |
| 2017-08-31 | Not split by product in the filing $2.46M 100.00% | $2.46M |
| 2016-08-31 | Not split by product in the filing $641.00K 100.00% | $641.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2025-12-31 | Not split by product $0.00 | $0.00 |
| 2025-09-30 | Not split by product $0.00 | $0.00 |
| 2025-06-30 | Not split by product $0.00 | $0.00 |
| 2025-03-31 | Not split by product $2.00M 100.00% | $2.00M |
| 2023-12-31 | Not split by product $0.00 | $0.00 |
| 2023-09-30 | Not split by product $0.00 | $0.00 |
| 2023-06-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2023-03-31 | Not split by product $666.00K 100.00% | $666.00K |
| 2022-12-31 | Not split by product $681.00K 100.00% | $681.00K |
| 2022-09-30 | Not split by product $682.00K 100.00% | $682.00K |
| 2022-06-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2022-03-31 | Not split by product $666.00K 100.00% | $666.00K |
| 2021-11-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2021-09-30 | Not split by product $682.00K 100.00% | $682.00K |
| 2021-08-31 | Not split by product $683.00K 100.00% | $683.00K |
| 2021-06-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2021-05-31 | Not split by product $681.00K 100.00% | $681.00K |
| 2021-03-31 | Not split by product $666.00K 100.00% | $666.00K |
| 2021-02-28 | Not split by product $665.00K 100.00% | $665.00K |
| 2020-11-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2020-08-31 | Not split by product $681.00K 100.00% | $681.00K |
| 2020-05-31 | Not split by product $681.00K 100.00% | $681.00K |
| 2020-02-29 | Not split by product $674.00K 100.00% | $674.00K |
| 2019-11-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2019-08-31 | Not split by product $681.00K 100.00% | $681.00K |
| 2019-05-31 | Not split by product $682.00K 100.00% | $682.00K |
| 2019-02-28 | Not split by product $666.00K 100.00% | $666.00K |
| 2018-11-30 | Not split by product $674.00K 100.00% | $674.00K |
| 2018-08-31 | Not split by product $617.00K 100.00% | $617.00K |
| 2018-05-31 | Not split by product $617.00K 100.00% | $617.00K |
| 2018-02-28 | Not split by product $604.00K 100.00% | $604.00K |
| 2017-11-30 | Not split by product $611.00K 100.00% | $611.00K |
| 2017-08-31 | Not split by product $618.00K 100.00% | $618.00K |
| 2017-05-31 | Not split by product $617.00K 100.00% | $617.00K |
| 2017-02-28 | Not split by product $611.00K 100.00% | $611.00K |
| 2016-11-30 | Not split by product $610.00K 100.00% | $610.00K |
| 2016-08-31 | Not split by product $929.00K 100.00% | $929.00K |
| 2016-05-31 | Not split by product -$163.00K 100.00% | -$163.00K |
| 2016-02-29 | Not split by product $125.00K 100.00% | $125.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |